ArticleDiscover oncology2024

Association of residual ductal carcinoma in situ with breast cancer treatment outcomes after neoadjuvant chemotherapy according to hormone receptor status.

Eunju Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.